NeuroBo Pharmaceuticals | 4:持股变动声明-高管 Woodworth Marshall H
03/05 10:21
NeuroBo Pharmaceuticals | 4:持股变动声明-董事 Tursi James Patrick
2023/12/05 06:12
NeuroBo Pharmaceuticals | 3:首次持股声明-董事 Tursi James Patrick
2023/11/03 04:39
NeuroBo Pharmaceuticals | 3:首次持股声明-高管 Woodworth Marshall H
2023/10/31 04:31
NeuroBo Pharmaceuticals | 4:持股变动声明-高管 Kim Hyung Heon
2023/08/15 04:10
NeuroBo Pharmaceuticals | 4:持股变动声明-董事 KOVEN ANDREW I
2023/07/28 18:19
NeuroBo Pharmaceuticals | 4:持股变动声明-董事 Salsbury Michael
2023/07/28 18:17
NeuroBo Pharmaceuticals | 4:持股变动声明-董事 STRICKLAND D GORDON
2023/07/28 18:15
NeuroBo Pharmaceuticals | 4:持股变动声明-董事 GROVES JASON L
2023/07/28 18:13
NeuroBo Pharmaceuticals | 4:持股变动声明-董事 Glickman Mark A
2023/07/28 18:11
NeuroBo Pharmaceuticals | 4:持股变动声明-董事 Kim Na Yeon
2023/07/28 18:08
NeuroBo Pharmaceuticals | 4/A:持股变动声明(修正)-董事 Kim Na Yeon
2023/07/28 18:02
NeuroBo Pharmaceuticals | 3:首次持股声明-董事 Glickman Mark A
2023/05/12 21:44
NeuroBo Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Strategic Risk, LLC.(6.3%)
2023/03/29 03:30
NeuroBo Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Altium Growth Fund, LP(0%),Altium Capital Management, LP(0%)等
2023/02/15 01:35
NeuroBo Pharmaceuticals | 3:首次持股声明-高管 Hooker Joseph
2023/01/19 05:15
NeuroBo Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Dong-A ST Co., Ltd.(65.5%)
2022/12/30 08:43
NeuroBo Pharmaceuticals | 3:首次持股声明-股东 GOLDMAN SACHS GROUP INC
2022/11/23 05:46
NeuroBo Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Altium Capital Management, LP EIN:(7.7%),Altium Growth Fund, LP EIN:(7.7%)等
2022/11/18 06:08
NeuroBo Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Dong-A ST Co., Ltd.(2.4%)
2022/11/11 05:14
暂无数据
暂无数据